Literature DB >> 2897834

The effects of antihypertensive agents on serum lipids and lipoproteins.

C K Lardinois1, S L Neuman.   

Abstract

Hypertension is a major risk factor for arteriosclerotic vascular disease. Despite intensive antihypertensive intervention, the risk of cardiovascular disease has not declined appreciably. Many of the antihypertensive agents have been shown to elevate total serum cholesterol and triglyceride levels or lower the high-density lipoprotein-cholesterol level. Thus, the antihypertensive agents chosen may negate the beneficial effects of a lower blood pressure. Our purpose is to review all available antihypertensive medications and their influence on lipoprotein metabolism. Choosing the antihypertensive therapy least likely to worsen or precipitate other known cardiovascular risk factors is important. Cost and side effect profiles must also be considered in choosing the best antihypertensive regimen for your patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897834

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  23 in total

1.  Metabolic effects of carteolol and dilevalol in essential hypertension.

Authors:  T Baba; K Takebe; T Tomiyama
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Antiatherogenic effects of calcium-channel blockers: possible mechanisms of action.

Authors:  P D Henry
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

4.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.

Authors:  G J Macphee; C A Howie; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 5.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

6.  Drug treatment in hypertension--metabolic side effects of drugs.

Authors:  P Little; A Trafford; G Girling; A Hasler; A Craven
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 7.  Lipid effects of antihypertensive medications.

Authors:  Roderick Deano; Matthew Sorrentino
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

8.  Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.

Authors:  J E Carlsen; L Køber; C Torp-Pedersen; P Johansen
Journal:  BMJ       Date:  1990-04-14

Review 9.  Adverse metabolic effects of antihypertensive drugs. Implications for treatment.

Authors:  H G Preuss; J F Burris
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

Review 10.  Torasemide in comparison with thiazides in the treatment of hypertension.

Authors:  P Baumgart
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.